药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arbutamine
Methscopolamine
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.
Arbutamine
Thonzylamine
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.
Arbutamine
Butylscopolamine
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.
Arbutamine
Imidafenacin
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Imidafenacin.
Arbutamine
Trimebutine
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.
Arbutamine
Dexetimide
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.
Arbutamine
Aclidinium
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
Arbutamine
Dimetindene
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.
Arbutamine
Hexocyclium
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.
Arbutamine
Mepenzolate
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.
Arbutamine
Isopropamide
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
Arbutamine
Solifenacin
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Arbutamine
Diphenidol
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Diphenidol.
Arbutamine
Flavoxate
Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Arbutamine
Methylene blue
Flibanserin may increase the serotonergic activities of Methylene blue.
Arbutamine
Alaproclate
The risk or severity of adverse effects can be increased when Flibanserin is combined with Alaproclate.
Arbutamine
Ritanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Ritanserin.
Arbutamine
Levomilnacipran
The risk or severity of adverse effects can be increased when Flibanserin is combined with Levomilnacipran.
Arbutamine
Dapoxetine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Dapoxetine.
Arbutamine
Sibutramine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Sibutramine.